How Kidney Function Predicts Patient Survival and Risks

Consequently, evaluating kidney function accurately remains a cornerstone of modern nephrology. Specifically, in clinical practice, doctors rely heavily on the glomerular filtration rate to make treatment choices. While direct measurement of this value is the reference standard, clinicians usually estimate it. Fortunately, a recent Swedish cohort study provides important clarity on this issue. Furthermore, it confirms how both methods predict mortality and kidney failure.

The Stockholm Study on Glomerular Filtration Rate

To compare these diagnostic methods, researchers evaluated 6,174 adult patients in Stockholm over a ten-year period. Specifically, they performed direct measurements using iohexol clearance testing. Additionally, they calculated estimated values using creatinine, cystatin C, or both. Over a median follow-up of nearly six years, almost one-third of the participants died. Consequently, investigators analyzed how different baseline rates predicted these major outcomes.

Confirming the Diagnostic Threshold

The research team found that a measured GFR of 60 mL/min/1.73 m² is a critical clinical threshold. For example, compared with normal kidney function, patients at this threshold had a 21 percent higher mortality rate. Furthermore, their risk of developing kidney failure requiring replacement therapy increased nearly threefold. Because these risks are so high, the study strongly supports the current global CKD definition. Therefore, clinicians can confidently use this diagnostic limit in daily practice.

Comparing Estimated and Measured Methods

To optimize patient care, clinicians must understand the differences between various estimation equations. The study compared measured GFR with three common clinical calculations. Interestingly, the combined creatinine-cystatin C equation aligned closely with measured outcomes. On the other hand, the creatinine-only equation underestimated the risks of mortality. Conversely, the cystatin C-only equation overestimated the patient’s mortality risk. Thus, using both biomarkers provides the most reliable clinical assessment.

Frequently Asked Questions

Q1: Why is the threshold of 60 mL/min/1.73 m² important in defining chronic kidney disease?

This threshold represents a critical point where clinical risks increase. Specifically, patients at this level face a 21 percent higher mortality rate. Furthermore, they have a nearly threefold increase in kidney failure risk compared to those with normal function.

Q2: Which estimated GFR equation is most accurate for predicting clinical risk?

The equation that combines both plasma creatinine and cystatin C provides the most accurate risk assessment. Consequently, this combined calculation aligns closely with the reference standard of directly measured GFR.

Q3: How do creatinine-only and cystatin C-only equations compare to direct GFR measurements?

The creatinine-only equation tends to underestimate mortality risk. Conversely, the cystatin C-only equation tends to overestimate this risk, making the combined test the preferred approach.

References

1. Fu EL et al. Measured and Estimated Glomerular Filtration Rates and Risk of Adverse Health Outcomes. JAMA. 2026 Jun 04. doi: 10.1001/jama.2026.9639. PMID: 42240159.
2. Potluri VS, et al. Precision, pragmatism, and emerging paradigms in determining kidney filtration function. JAMA. 2026 Jun 04. doi: 10.1001/jama.2026.9991.